No position
FDA approves Viridian Therapeutics' Veligrotug?
Ends Jun 30, 2026- Implied probability
- 31%
- Current value
- $62
- Potential payout
- $200
- Potential profit
- $138
- Multiplier
- 3.23x
- User PnL
- -$0.41
Polymarket Trader
0xa4744e97E961cfdBf513911522E343ED390bFD60-1781273277005
0xa4744e97e961cfdbf513911522e343ed390bfd60
Public profile Partial data Delayed section
- Open value
- $62
- Realized PnL
- $0
- Win rate
- Unavailable
- Open positions
- 2
- Closed positions
- 0
- Markets traded
- Unavailable
Current Predictions
Open positions
No position
FDA approves GSK & Spero Therapeutics' Tebipenem HBr?
Ends Jun 18, 2026- Implied probability
- 0%
- Current value
- $0
- Potential payout
- $110
- Potential profit
- $110
- User PnL
- -$46.17
Resolved Context
Closed positions
No closed positions returned for this trader.
Trades
Recent trades
Latest visible trades for this Polymarket trader.
- FDA approves GSK & Spero Therapeutics' Tebipenem HBr?No 33.1% 140 shares
- FDA approves GSK & Spero Therapeutics' Tebipenem HBr?No 57% 7 shares
- FDA approves GSK & Spero Therapeutics' Tebipenem HBr?No 57% 54 shares
- FDA approves GSK & Spero Therapeutics' Tebipenem HBr?No 44% 8 shares
- FDA approves GSK & Spero Therapeutics' Tebipenem HBr?No 40% 30 shares
- FDA approves GSK & Spero Therapeutics' Tebipenem HBr?No 36.2% 151 shares
- FDA approves Viridian Therapeutics' Veligrotug?No 33% 46 shares
- FDA approves Viridian Therapeutics' Veligrotug?No 31% 100 shares
- FDA approves Viridian Therapeutics' Veligrotug?No 31% 3.23 shares